5-O-demethyl-22,23-dihydro-avermectin A1a en es it fr

5-O-demethyl-22,23-dihydro-avermectin A1a Brand names, 5-O-demethyl-22,23-dihydro-avermectin A1a Analogs

5-O-demethyl-22,23-dihydro-avermectin A1a Brand Names Mixture

  • No information avaliable

5-O-demethyl-22,23-dihydro-avermectin A1a Chemical_Formula

C12H22O11

5-O-demethyl-22,23-dihydro-avermectin A1a RX_link

http://www.rxlist.com/cgi/generic2/lactulose.htm

5-O-demethyl-22,23-dihydro-avermectin A1a fda sheet

5-O-demethyl-22,23-dihydro-avermectin A1a msds (material safety sheet)

5-O-demethyl-22,23-dihydro-avermectin_A1a MSDS

5-O-demethyl-22,23-dihydro-avermectin A1a Synthesis Reference

No information avaliable

5-O-demethyl-22,23-dihydro-avermectin A1a Molecular Weight

342.296 g/mol

5-O-demethyl-22,23-dihydro-avermectin A1a Melting Point

173 - 178 oC

5-O-demethyl-22,23-dihydro-avermectin A1a H2O Solubility

764 mg/mL

5-O-demethyl-22,23-dihydro-avermectin A1a State

Solid

5-O-demethyl-22,23-dihydro-avermectin A1a LogP

-5.19

5-O-demethyl-22,23-dihydro-avermectin A1a Dosage Forms

Liquid; Powder; Solution; Syrup

5-O-demethyl-22,23-dihydro-avermectin A1a Indication

For the treatment of constipation and hepatic encephalopathy.

5-O-demethyl-22,23-dihydro-avermectin A1a Pharmacology

Therapeutically, lactulose has laxative and ammonia-detoxifying actions. In treating constipation lactulose metabolites draw water into the bowel, causing a cathartic effect through osmotic action.

5-O-demethyl-22,23-dihydro-avermectin A1a Absorption

Poorly absorbed from the gastrointestinal tract as no human enzyme that is capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue.

5-O-demethyl-22,23-dihydro-avermectin A1a side effects and Toxicity

LD50=18.2 g/kg (oral, rat). Side effects include diarrhea and resultant dehydration.

5-O-demethyl-22,23-dihydro-avermectin A1a Patient Information

http://www.drugs.com/MTM/labetalol.html

5-O-demethyl-22,23-dihydro-avermectin A1a Organisms Affected

Humans and other mammals